Nanoscribe – the world leader in manufacturing 3D printers and maskless lithography systems for microfabrication technology, presented today the new IP-Visio printing material for life science applications. Material is non-cytotoxic, low-fluorescent and designed for the 3D Microfabrication of biocompatible microstructures. With IP-Visio, Nanoscribe’s 3D printers open up the way to produce intricate, filigree microenvironments needed in 3D cell culture and tissue engineering.
Nanoscribe’s 3D printing technology give rise to numerous ways to produce 3D microenvironments that resemble the natural surrounding conditions of cells known in the human body. The technology enables the direct fabrication of intricate 3D microstructures with outstanding shape accuracy, resulting in pioneering work in 3D cell scaffolds. Research results have been published, for example, on retinal tissue engineering, cancer research, and the first 3D-printed blood-brain barrier model for drug screening.
The IP-Visio printing material is non-cytotoxic according to ISO 10993-5, what makes it suitable for cell-friendly 3D scaffolds. With this material, high-precision microstructures can be fabricated to mimic realistic and high-precision microenvironments. An exemplary application is multi-cell scaffolds that serve as supporting material to seed and study cells in 3D.
Moreover, IP-Visio shows a very low autofluorescence. This property allows a clear view through the printed scaffolds. Scientists can analyze cellular components and processes by means of fluorescence microscopy without interference of the printed structures.
The new product is launched at the SPIE BiOS and Photonics West conference in San Francisco, the world-leading event in photonics and optics. You can find Nanoscribe presenting its solutions at SPIE BiOS (booth 8256) and Photonics West (hall E, Booth 3254).
Source: www.nanoscribe.com